Stay updated on IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T06:13:35.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T02:23:31.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the prior government funding status notice (v3.4.1) was removed. The core study details and data remain unchanged.
    Difference
    0.4%
    Check dated 2026-02-11T12:22:43.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Added a government funding/status notice and updated the site version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:41:46.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Glossary toggle and new metadata labels ('Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0') appear on the page, while older labels ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4') are removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:20:29.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now listed and Revision: v3.3.3 has been removed.
    Difference
    0.0%
    Check dated 2026-01-14T02:58:27.000Z thumbnail image

Stay in the know with updates to IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page.